← All companies

DNLI

Denali Therapeutics Inc.

DNLI Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$24.17

+1.02 +4.41%

Key statistics

from XBRL data in SEC filings

Market cap

$3.84B

Revenue (TTM)

$0.00

Net income (TTM)

-$508M

EPS (TTM)

$-2.88

P/E ratio

—

Dividend yield

—

Free cash flow

-$422M

Cash

$388M

Total assets

$1.27B

Gross margin

—

52-week range

$12.58 – $27.30

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Completed an acquisition or disposition Jul 28, 2026 8-K Entered a material agreement; Regulation FD disclosure Jun 18, 2026 8-K Shareholder vote results Jun 4, 2026 8-K Regulation FD disclosure May 22, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Terminated a material agreement Apr 3, 2026 8-K Took on a direct financial obligation; Regulation FD disclosure Mar 31, 2026 8-K Regulation FD disclosure Mar 25, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K Regulation FD disclosure Jan 6, 2026 8-K Entered a material agreement; Other events Dec 10, 2025 8-K Regulation FD disclosure; Other events Dec 4, 2025 8-K Entered a material agreement Dec 4, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Regulation FD disclosure Oct 14, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Results of operations (earnings release) Aug 11, 2025 8-K Regulation FD disclosure Jul 7, 2025 8-K Entered a material agreement; Shareholder vote results Jun 3, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release) May 6, 2025 8-K Regulation FD disclosure Apr 2, 2025 8-K Regulation FD disclosure Mar 5, 2025 8-K Entered a material agreement; Terminated a material agreement; Results of operations (earnings release) Feb 27, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Regulation FD disclosure Jan 13, 2025 8-K Regulation FD disclosure Jan 7, 2025 8-K Amended charter or bylaws Nov 18, 2024 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release) Nov 6, 2024 8-K Regulation FD disclosure Oct 10, 2024 10-Q Quarter ended 2024-06-30 Aug 1, 2024 8-K Results of operations (earnings release) Aug 1, 2024 8-K Shareholder vote results May 31, 2024 10-Q Quarter ended 2024-03-31 May 7, 2024 8-K Results of operations (earnings release) May 7, 2024 10-K Fiscal year ended 2023-12-31 Feb 28, 2024